At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ECOR Electrocore LLC
Not Yet Opened 11-09 16:00:00 EST
7.18
-0.07
-0.97%
盘后7.32
+0.14+1.95%
19:55 EST
High8.04Low7.03Vol421.99K
Open7.41D1 Closing7.25Amplitude13.89%
Mkt Cap66.24MTradable Cap44.45MTotal Shares9.23M
T/O3.15MT/O Rate6.82%Tradable Shares6.19M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Inogen Q3 Revenue Falls on Lower International Sales
Reuters  ·  11-06
Inogen Q3 Revenue Falls on Lower International Sales
electroCore Participates in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Reuters  ·  11-05
electroCore Participates in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
electroCore, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary
Reuters  ·  11-05
electroCore, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary
electroCore Q3 Revenue Rises on VA Prescription Growth
Reuters  ·  11-05
electroCore Q3 Revenue Rises on VA Prescription Growth
electroCore Q3 2026 Net Loss Narrows 61% to $1.34 Million; Q3 2026 Net Sales Rise 12% to $9.69 Million
Reuters  ·  11-05
electroCore Q3 2026 Net Loss Narrows 61% to $1.34 Million; Q3 2026 Net Sales Rise 12% to $9.69 Million
electroCore Q3 EPS $(0.13) Beats $(0.27) Estimate, Sales $9.690M Miss $10.928M Estimate
Benzinga Earnings  ·  11-05
electroCore Q3 EPS $(0.13) Beats $(0.27) Estimate, Sales $9.690M Miss $10.928M Estimate
electroCore Q3 Net Income USD -1.339 Million
Reuters  ·  11-05
electroCore Q3 Net Income USD -1.339 Million
H.C. Wainwright Sticks to Its Buy Rating for Electrocore (ECOR)
TIPRANKS  ·  11-04
H.C. Wainwright Sticks to Its Buy Rating for Electrocore (ECOR)
electroCore Seeks FDA Clearance for Quell to Treat Chemotherapy-Induced Neuropathy
Reuters  ·  10-28
electroCore Seeks FDA Clearance for Quell to Treat Chemotherapy-Induced Neuropathy
electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (Cipn)
THOMSON REUTERS  ·  10-28
electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (Cipn)
electroCore Study Suggests Vagus Nerve Stimulation Accelerates Visual Skill Learning
Reuters  ·  10-27
electroCore Study Suggests Vagus Nerve Stimulation Accelerates Visual Skill Learning
electroCore Director Thomas J. Errico Acquires Common Shares Worth $49,081.50
Reuters  ·  09-22
electroCore Director Thomas J. Errico Acquires Common Shares Worth $49,081.50
H.C. Wainwright Keeps Their Buy Rating on Electrocore (ECOR)
TIPRANKS  ·  09-22
H.C. Wainwright Keeps Their Buy Rating on Electrocore (ECOR)
RBC Capital Remains a Buy on Ecora Royalties PLC (ECOR)
TIPRANKS  ·  09-18
RBC Capital Remains a Buy on Ecora Royalties PLC (ECOR)
electroCore to Join H.C. Wainwright Global Investment Conference Fireside Chat
Reuters  ·  09-10
electroCore to Join H.C. Wainwright Global Investment Conference Fireside Chat
electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers
THOMSON REUTERS  ·  09-09
electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers
electroCore: Joshua Lev Will Continue Performing His Current CFO Responsibilities
THOMSON REUTERS  ·  09-09
electroCore: Joshua Lev Will Continue Performing His Current CFO Responsibilities
electroCore CFO and Interim President Joshua S. Lev Sells Common Shares Worth $169,020
Reuters  ·  08-26
electroCore CFO and Interim President Joshua S. Lev Sells Common Shares Worth $169,020
electroCore Director Thomas J. Errico Acquires 5,000 Common Shares for $49,272
Reuters  ·  08-17
electroCore Director Thomas J. Errico Acquires 5,000 Common Shares for $49,272
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Korro Bio (KRRO), Electrocore (ECOR) and BioLife Solutions (BLFS)
TIPRANKS  ·  08-07
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Korro Bio (KRRO), Electrocore (ECOR) and BioLife Solutions (BLFS)

Introduction

Company Name.
Electrocore LLC
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Issue price:
--